5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | NEUTRAL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.84▼ | 2.84▼ | 2.84▼ | 2.80▲ | 2.88▼ |
MA10 | 2.84▼ | 2.85▼ | 2.84▼ | 2.76▲ | 2.95▼ |
MA20 | 2.86▼ | 2.83▲ | 2.83▲ | 2.86▼ | 2.48▲ |
MA50 | 2.84▲ | 2.79▲ | 2.75▲ | 3.08▼ | 1.37▲ |
MA100 | 2.80▲ | 2.75▲ | 2.82▲ | 2.36▲ | 1.21▲ |
MA200 | 2.75▲ | 2.91▼ | 2.89▼ | 1.50▲ | 6.66▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.003▼ | -0.002▼ | 0.004▲ | -0.050▼ |
RSI | 47.714▼ | 54.044▲ | 57.069▲ | 49.256▼ | 59.310▲ |
STOCH | 26.852 | 35.198 | 54.018 | 63.481 | 28.688 |
WILL %R | -80.000▼ | -50.000 | -40.000 | -47.519 | -71.351 |
CCI | -58.333 | -4.762 | 24.145 | 36.433 | -18.071 |
Monday, September 01, 2025 05:28 AM
SILICON VALLEY, CA, Sept 1, 2025 - (JCN Newswire) - - ABVC BioPharma, Inc.(NASDAQ: ABVC) (ABVC or the Company), a clinical-stage biopharmaceutical company developing innovative therapies in oncology, ...
|
Monday, September 01, 2025 05:28 AM
SILICON VALLEY, CA, Sept 1, 2025 - (JCN Newswire) - - ABVC BioPharma, Inc.(NASDAQ: ABVC) (ABVC or the Company), a clinical-stage biopharmaceutical company developing innovative therapies in oncology, ...
|
Thursday, August 14, 2025 04:12 AM
Abvc BioPharma operates at the intersection of pharmaceutical research and nature-based medicine, developing new drugs using botanical sources. The company’s core business lies in carrying drug and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 2.85 | 2.8933 | 2.8201 | 2.84 | 45,118 |
15/09/25 | 2.85 | 2.9007 | 2.78 | 2.87 | 80,284 |
12/09/25 | 2.72 | 2.86 | 2.72 | 2.85 | 56,800 |
11/09/25 | 2.70 | 2.80 | 2.68 | 2.77 | 63,200 |
10/09/25 | 2.70 | 2.75 | 2.635 | 2.68 | 65,300 |
09/09/25 | 2.72 | 2.75 | 2.66 | 2.75 | 53,600 |
08/09/25 | 2.70 | 2.75 | 2.63 | 2.72 | 58,400 |
05/09/25 | 2.71 | 2.73 | 2.55 | 2.65 | 64,300 |
04/09/25 | 2.71 | 2.73 | 2.51 | 2.72 | 133,600 |
03/09/25 | 2.76 | 2.84 | 2.68 | 2.71 | 67,900 |
|
|
||||
|
|
||||
|
|